Thrombopoietin mimetics

Details for Australian Patent Application No. 2001274938 (hide)

Owner SmithKline Beecham Corporation Glaxo Group Limited

Inventors Jenkins, Julian; Price, Alan T.; Eppley, Daniel F.; Duffy, Kevin J.; Shaw, Antony N.; Luengo, Juan I.; Liu, Nannan; Wiggall, Kenneth; Visonneau, Sophie; Erickson-Miller, Connie L

Agent Davies Collison Cave

Pub. Number AU-B-2001274938

PCT Pub. Number WO01/89457

Priority 60228929 30.08.00 US; 60207084 25.05.00 US

Filing date 24 May 2001

Wipo publication date 3 December 2001

Acceptance publication date 19 January 2006

International Classifications

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/4152 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/655 (2006.01) - Azo (NN), diazo (N), azoxy (NON or N(O)N), azido (N) or diazoamino (NNN) compounds

C07D 213/79 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 231/20 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 257/04 (2006.01) Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

C07D 401/02 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/02 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

19 January 2006 Application Accepted

  Published as AU-B-2001274938

11 May 2006 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 06 Apr 2006. Address for service in Australia - Davies Collison Cave 1 Little Collins Street Melbourne VIC 3000 2002

18 May 2006 Standard Patent Sealed

28 September 2006 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 06 Apr 2006 2002

23 August 2007 Assignment Registered

  SmithKline Beecham Corporation; Glaxo Group Limited The patent has been assigned to SmithKline Beecham Corporation

17 April 2008 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 19 Mar 2008. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

21 August 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 19 Mar 2008 2002 2002234455 ID Biomedical Corporation The nature of the amendment is as shown in the statement(s) filed 30 Jan 2008

19 August 2010 Alteration of Name

  The name of the patentee has been altered to GlaxoSmithKline LLC 2002

25 November 2010 Extension of Term of Standard Patents

  GlaxoSmithKline LLC The earliest first regulatory approval date provided by the patentee 16 Jul 2010 For the goods REVOLADE eltrombopag

23 December 2010 Extension of Term of Standard Patents

  GlaxoSmithKline LLC The earliest first regulatory approval date provided by the patentee 16 Jul 2010 For the goods REVOLADE eltrombopag Address for service in Australia: Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

28 April 2011 Extension granted

  GlaxoSmithKline LLC The earliest first regulatory approval date provided by the patentee 16 Jul 2010 For the goods REVOLADE eltrombopag Extension of Term of patent pursuant to Section 77 expires on 16 Jul 2025

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001274939

2001274937